203 related articles for article (PubMed ID: 32292048)
1. Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement.
Zanoli L; Mikhailidis DP; Bruno RM; Abreu MT; Danese S; Eliakim R; Gionchetti P; Katsanos KH; Kirchgesner J; Koutroubakis IE; Kucharzik T; Lakatos PL; Nguyen GC; Papa A; Vavricka SR; Wilkinson IB; Boutouyrie P
Angiology; 2020 Sep; 71(8):689-697. PubMed ID: 32292048
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease.
Zanoli L; Ozturk K; Cappello M; Inserra G; Geraci G; Tuttolomondo A; Torres D; Pinto A; Duminuco A; Riguccio G; Aykan MB; Mulé G; Cottone S; Perna AF; Laurent S; Fatuzzo P; Castellino P; Boutouyrie P
J Am Heart Assoc; 2019 Feb; 8(3):e010942. PubMed ID: 30712441
[TBL] [Abstract][Full Text] [Related]
3. Arterial structure and function in inflammatory bowel disease.
Zanoli L; Rastelli S; Inserra G; Castellino P
World J Gastroenterol; 2015 Oct; 21(40):11304-11. PubMed ID: 26523102
[TBL] [Abstract][Full Text] [Related]
4. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs.
Zanoli L; Rastelli S; Inserra G; Lentini P; Valvo E; Calcagno E; Boutouyrie P; Laurent S; Castellino P
Atherosclerosis; 2014 Jun; 234(2):346-51. PubMed ID: 24732573
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2 and arterial stiffness evaluation in patients with inflammatory bowel diseases.
Theocharidou E; Tellis CC; Mavroudi M; Soufleris K; Gossios TD; Giouleme O; Athyros VG; Tselepis AD; Karagiannis A
J Crohns Colitis; 2014 Sep; 8(9):936-44. PubMed ID: 24529818
[TBL] [Abstract][Full Text] [Related]
6. Pulse wave velocity measurement as a marker of arterial stiffness in pediatric inflammatory bowel disease: a pilot study.
Lurz E; Aeschbacher E; Carman N; Schibli S; Sokollik C; Simonetti GD
Eur J Pediatr; 2017 Jul; 176(7):983-987. PubMed ID: 28508156
[TBL] [Abstract][Full Text] [Related]
7. [Atherosclerosis and cardiovascular risk in patients with inflammatory bowel disease].
Mironova OI; Isaikina MA; Khasieva SA
Ter Arkh; 2021 Dec; 93(12):1533-1538. PubMed ID: 36286684
[TBL] [Abstract][Full Text] [Related]
8. Children with inflammatory bowel disease already have an altered arterial pulse wave.
Pivac VT; Herceg-Čavrak V; Hojsak I; Mišak Z; Jadrešin O; Kolaček S
Eur J Pediatr; 2023 Apr; 182(4):1771-1779. PubMed ID: 36763192
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.
Cappello M; Licata A; Calvaruso V; Bravatà I; Aiello A; Torres D; Della Corte V; Tuttolomondo A; Perticone M; Licata G; Craxì A; Cammà C
Eur J Intern Med; 2017 Jan; 37():83-89. PubMed ID: 27773555
[TBL] [Abstract][Full Text] [Related]
10. Endothelial and Cardiac Dysfunction in Inflammatory Bowel Diseases: Does Treatment Modify the Inflammatory Load on Arterial and Cardiac Structure and Function?
Triantafyllou C; Nikolaou M; Ikonomidis I; Bamias G; Papaconstantinou I
Curr Vasc Pharmacol; 2020; 18(1):27-37. PubMed ID: 30488796
[TBL] [Abstract][Full Text] [Related]
11. Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis.
Zanoli L; Rastelli S; Granata A; Inserra G; Empana JP; Boutouyrie P; Laurent S; Castellino P
J Hypertens; 2016 May; 34(5):822-9. PubMed ID: 26882040
[TBL] [Abstract][Full Text] [Related]
12. Association between aortic stiffness and left ventricular function in inflammatory bowel disease.
Aslan AN; Sarı C; Özer Sarı S; Tayfur Yürekli Ö; Baştuğ S; Sivri S; Ersoy O; Bozkurt E
Cardiol J; 2016; 23(2):202-10. PubMed ID: 26779973
[TBL] [Abstract][Full Text] [Related]
13. "Inflammation and arterial stiffness in humans".
Jain S; Khera R; Corrales-Medina VF; Townsend RR; Chirinos JA
Atherosclerosis; 2014 Dec; 237(2):381-90. PubMed ID: 25463062
[TBL] [Abstract][Full Text] [Related]
14. Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease.
Fan F; Galvin A; Fang L; White DA; Moore XL; Sparrow M; Cicuttini F; Dart AM
J Inflamm (Lond); 2014; 11(1):29. PubMed ID: 25337037
[TBL] [Abstract][Full Text] [Related]
15. Arterial stiffness is increased in patients with inflammatory bowel disease.
Zanoli L; Cannavò M; Rastelli S; Di Pino L; Monte I; Di Gangi M; Boutouyrie P; Inserra G; Laurent S; Castellino P
J Hypertens; 2012 Sep; 30(9):1775-81. PubMed ID: 22796713
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease.
Zanoli L; Boutouyrie P; Fatuzzo P; Granata A; Lentini P; Oztürk K; Cappello M; Theocharidou E; Tuttolomondo A; Pinto A; Cammà C; Licata A; Blanco J; Rastelli S; Inserra G; Castellino P; Laurent S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018026
[TBL] [Abstract][Full Text] [Related]
17. The oft-overlooked cardiovascular complications of inflammatory bowel disease.
Massironi S; Mulinacci G; Gallo C; Viganò C; Fichera M; Villatore A; Peretto G; Danese S
Expert Rev Clin Immunol; 2023 Apr; 19(4):375-391. PubMed ID: 36722283
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
[TBL] [Abstract][Full Text] [Related]
19. [Increased risk of venous thromboembolism and arterial cardiovascular events in patients with inflammatory bowel disease].
Lund Kristensen S; Ahlehoff O; Lindhardsen J; Gislason G; Nielsen OH; Hansen PR
Ugeskr Laeger; 2012 Nov; 174(48):3003-6. PubMed ID: 23195352
[TBL] [Abstract][Full Text] [Related]
20. Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?
Maldonado-Pérez MB; Castro-Laria L; Caunedo-Álvarez A; Montoya-García MJ; Giner-García M; Argüelles-Arias F; Romero-Gómez M; Vázquez-Gámez MÁ
J Clin Densitom; 2019; 22(2):195-202. PubMed ID: 30205986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
